Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MDI (Molecular Diagnostics) and Ventana team up on imaging:

This article was originally published in Clinica

Executive Summary

Tucson, Arizona-based Ventana Medical Systems has made an equity investment of $1.75 million in Molecular Diagnostics (MDI) and has purchased the rights to use Chicago-based MDI's AcCell automated microscopy workstation and Samba image analysis and telemedicine system software. "Our partnership with MDI significantly expands the breadth of imaging technologies available to Ventana," said Christopher Gleeson, Ventana's CEO. Access to the products will accelerate time to market, with launch date predicted in the second half of 2002.

Topics

UsernamePublicRestriction

Register

MT074049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel